Kilitch Drugs (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Kilitch Drugs |
|||
|
Price: ₹325.85 | ||
| 52 Week Low: ₹300.00 52 Week High: ₹470.00 |
|||
| Market Capital: 492.27 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Kilitch Drugs Share Price Target For 2024
- 1.1.1: Kilitch Drugs Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Kilitch Drugs Share Price Target For 2025
- 1.2.1: Kilitch Drugs Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Kilitch Drugs Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Kilitch Drugs Brief Company Overview
- 4: Kilitch Drugs Financial Performance
- 4.0.1: Is Kilitch Drugs A Good Buy For Long Term?
To predict the Kilitch Drugs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Kilitch Drugs Share Price Target For 2024
The line chart displays the monthly closing prices of Kilitch Drugs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Kilitch Drugs shares in 2024, see the table below.
Kilitch Drugs Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 338.75 (+3.95%) | Price Action: 08 Oct 2024 High |
| 2024 Target 2 | 335.35 (+2.91%) | Price Action: 13 Mar 2024 Low |
| 2024 Target 1 | 331.95 (+1.87%) | Price Action: 07 Jun 2024 High |
| Current Price | 325.85 | Kilitch Drugs's share price as of 26 Dec 2024 |
| Stop Loss 1 | 323.05 (-0.86%) | Fibonacci Retracement Level 71.80% |
| Stop Loss 2 | 319.7 (-1.89%) | Price Action: 25 Nov 2024 High |
| Stop Loss 3 | 316.4 (-2.91%) | Price Action: 03 Nov 2023 High |
Short-Term Technical Outlook
Current Technical Position: Kilitch Drugs is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹321.42 serves as the nearest technical reference point.
Historical Returns: 3-month: -5.09% | 6-month: -2.56% | 1-year: -11.77%
Kilitch Drugs Share Price Target For 2025
The line chart displays the monthly closing prices of Kilitch Drugs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Kilitch Drugs shares in 2025, see the table below.
Kilitch Drugs Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 441.9 (+35.61%) | Price Action: 06 Feb 2024 High |
| 2025 Target 2 | 436.18 (+33.85%) | Fibonacci Extension Level 64.90% |
| 2025 Target 1 | 429.95 (+31.94%) | Price Action: 16 Feb 2024 High |
| Current Price | 325.85 | Kilitch Drugs's share price as of 26 Dec 2024 |
| Stop Loss 1 | 300.2 (-7.88%) | Price Action: 25 Oct 2024 Low |
| Stop Loss 2 | 297.2 (-8.8%) | Price Action: Chart |
| Stop Loss 3 | 292.0 (-10.39%) | Price Action: 02 Nov 2023 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Kilitch Drugs is currently trading near its 52-week low of ₹300, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -11.77% | 3-year: +30.58% | 5-year: +155.77%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Kilitch Drugs Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹325.85 | ||
| 2024 | ₹384.97 | +18.14% | ₹390.74 |
| 2025 | ₹376.80 | -2.12% | ₹402.93 |
| 2026 | ₹444.70 | +18.02% | ₹460.53 |
| 2027 | ₹470.21 | +5.73% | ₹518.13 |
| 2028 | ₹575.73 | +22.44% | ₹584.37 |
| 2029 | ₹611.59 | +6.22% | ₹620.76 |
| 2030 | ₹575.25 | -5.94% | ₹633.33 |
| 2031 | ₹656.58 | +14.13% | ₹690.93 |
| 2032 | ₹674.75 | +2.76% | ₹748.53 |
| 2033 | ₹806.13 | +19.47% | ₹818.22 |
| 2034 | ₹838.21 | +3.97% | ₹850.78 |
| 2035 | ₹773.69 | -7.69% | ₹863.73 |
| 2036 | ₹868.46 | +12.24% | ₹921.33 |
| 2037 | ₹879.30 | +1.24% | ₹978.93 |
| 2038 | ₹1,036.53 | +17.88% | ₹1,052.08 |
| 2039 | ₹992.15 | -4.28% | ₹1,007.03 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Kilitch Drugs Brief Company Overview
Kilitch Drugs (India) Limited: A Pharmaceutical Powerhouse With a rich history dating back to 1978, Kilitch Drugs (India) Limited has established itself as a leading player in the Indian pharmaceutical industry. Headquartered in Mumbai, the company boasts a diverse product...
range catering to various therapeutic areas. Diverse Product Range: Injectable Products: Parenteral and nasal formulations, including gastroenterology, anti-inflammatory, and anti-infective drugs. Oral Formulations: Tablets, capsules, and powders covering antibiotics, anti-diabetics, and cardiovascular medications. Effervescent Products: ROIPAR, DUREGRA, and other effervescent tablets and powders. Nutritional Products: CELTINE, a nutritional supplement. Topical Skin Adhesive: C-Seal, a solution for wound closure. Cosmetics and Herbal Products: A range of oils, lotions, and herbal products for skin, personal, and hair care. Commitment to Innovation: Kilitch Drugs is driven by a commitment to developing and delivering high-quality pharmaceutical products. The company's dedicated research and development team ensures the continuous advancement of its product portfolio.Kilitch Drugs Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 492.27 Crore | Market valuation of Kilitch Drugs's shares. |
| Revenue (TTM) | 151.26 Crore | Total revenue generated by Kilitch Drugs over the past twelve months. |
| Net Income (TTM) | +12.58 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +2.41% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +8.31% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-8.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-60.1% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
18.01 | Company's total debt divided by total shareholder equity. |
| Total Debt | 31.64 Crore | Sum of Kilitch Drugs's current & long-term financial obligations. |
| Total Cash | 69.07 Crore | Total amount of liquid funds available to Kilitch Drugs. |
| Beta | 0.28 | Beta is less than 1 indicating that the Kilitch Drugs's price is less volatile than the market. |
Is Kilitch Drugs A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
